The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
November 20th 2024
Bimekizumab-bkzx is the first and only approved medication that targets both interleukin (IL) 17F and IL-17A.
November 13th 2024
CD19 CAR NK-Cell Therapy Achieves Significant Response in Patients with Leukemia, Lymphoma
March 9th 2020Treatment with cord blood-derived chimeric antigen receptor natural killer-cell therapy targeting CD19 resulted in clinical responses in relapsed or refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.
Read More
FDA Grants Fast Track Designation to Treatment for Systemic Sclerosis
March 3rd 2020The designation was granted to Emerald Health Pharmaceuticals’ EHP-101, an oral formulation of a novel aminoquinone synthetic derivative of cannabidiol endowed with dual peroxisome proliferator-activated receptor gamma and cannabinoid receptor type 2 agonist activity.
Read More
Survey Shows Patients Are Unaware of Resources Offered by Manufacturers of Medications
February 26th 2020A recent patient survey conducted by Human Care Services uncovered a genuine significant desire from patients for help from drug manufacturers in managing their conditions and drug regimens.
Read More
Talazoparib Associated with Antitumor Activity in Patients with DNA Damage Repair Mutations
February 24th 2020Monotherapy with talazoparib demonstrated encouraging antitumor activity in patients with DNA damage repair mutations and docetaxel pretreated metastatic castration-resistant prostate cancer.
Read More